These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2979004)

  • 21. Effect of cyclosporin-A, antimalarial drug, on lymphocyte proliferation of Balb/c mice in vitro.
    Upender M; Saxena QB
    Indian J Exp Biol; 1990 Sep; 28(9):880-2. PubMed ID: 2279783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potent and selective inhibition of in vitro lymphocyte migration by cyclosporine and dexamethasone.
    Ross JS; Bacon KB; Camp RD
    Immunopharmacol Immunotoxicol; 1990; 12(3):439-55. PubMed ID: 2176229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolactin as a modulator of lymphocyte responsiveness provides a possible mechanism of action for cyclosporine.
    Hiestand PC; Mekler P; Nordmann R; Grieder A; Permmongkol C
    Proc Natl Acad Sci U S A; 1986 Apr; 83(8):2599-603. PubMed ID: 2939454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunological studies on renal transplantation. III. Experimental studies on the immunosuppressive action of cyclosporin A].
    Matsuura T
    Nihon Hinyokika Gakkai Zasshi; 1984 Dec; 75(12):1857-65. PubMed ID: 6242058
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacodynamics of cyclosporine.
    Kahan BD; Yoshimura N; Pellis NR; Burstain T; Van Buren CT; Leinikki P; Schreiber RD; Roesel TR; Kerman RH
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):238-51. PubMed ID: 2947366
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of cyclosporin A on human lymphocyte responses in vitro. V. Analysis of responding T lymphocyte subpopulations in primary MLR with monoclonal antibodies.
    Hess AD; Donnenberg AD; Tutschka PJ; Santos GW
    J Immunol; 1983 Feb; 130(2):717-21. PubMed ID: 6217251
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of cyclosporin-A on human lymphocyte responses in vitro--induction of tolerance to alloantigens.
    Hess AD; Tutschka PJ; Santos GW
    Transplant Proc; 1981 Mar; 13(1 Pt 1):374-8. PubMed ID: 6455794
    [No Abstract]   [Full Text] [Related]  

  • 28. Cyclosporin A.
    Morris PJ
    Transplantation; 1981 Nov; 32(5):349-54. PubMed ID: 6460358
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of cyclosporin A on human lymphocyte responses in vitro. III. CsA inhibits the production of T lymphocyte growth factors in secondary mixed lymphocyte responses but does not inhibit the response of primed lymphocytes to TCGF.
    Hess AD; Tutschka PJ; Santos GW
    J Immunol; 1982 Jan; 128(1):355-9. PubMed ID: 6459374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of cyclosporine A on T lymphocytes and accessory cells from human blood.
    Granelli-Piperno A; Keane M
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):136-42. PubMed ID: 2966477
    [No Abstract]   [Full Text] [Related]  

  • 31. Cyclosporin A inhibits IL 2-driven proliferation of human alloactivated T cells.
    Buurman WA; Ruers TJ; Daemen IA; van der Linden CJ; Groenewegen G
    J Immunol; 1986 Jun; 136(11):4035-9. PubMed ID: 2939138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased frequency of kidney allograft rejection in recipients with cyclosporine and/or steroid-resistant lymphoid responses.
    Bowes LG; Dumble LJ; Francis DM; Macdonald IM; Clunie GJ; Kincaid-Smith P
    Transplant Proc; 1990 Oct; 22(5):2139-40. PubMed ID: 2145672
    [No Abstract]   [Full Text] [Related]  

  • 33. Alloantigen-specific suppressor T cells are not inhibited by cyclosporin A, but do require IL 2 for activation.
    Bucy RP
    J Immunol; 1986 Aug; 137(3):809-13. PubMed ID: 2424984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resting lymphocytes are the target of cyclosporin action.
    Kimball PM; Gamaz N; Sell S
    Diabetes Res; 1988 Mar; 7(3):113-6. PubMed ID: 3262027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased risk of rejection in renal transplant recipients with in vitro cyclosporin-resistant lymphoid responses.
    Bowes LG; Dumble LJ; Clunie GJ; Francis DM; Macdonald IM; Kincaid-Smith P
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1470-1. PubMed ID: 2523587
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunosuppression failure: a function of lymphocyte steroid and cyclosporin resistance.
    House AK; Potter JM; Pedersen KE; Kinnear BF; Walker KB
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1573-4. PubMed ID: 2652511
    [No Abstract]   [Full Text] [Related]  

  • 37. Restoration of allogeneic responsiveness of lymphocytes from cyclosporin A-treated animals with interleukin 2.
    Wang BS; Heacock EH; Zheng CX; Tilney NL; Mannick JA
    Transplantation; 1982 Apr; 33(4):454-6. PubMed ID: 6978560
    [No Abstract]   [Full Text] [Related]  

  • 38. IL-2 can enhance the cyclosporin A-mediated inhibition of Theileria parva-infected T cell proliferation.
    Eichhorn M; Magnuson NS; Reeves R; Williams RO; Dobbelaere DA
    J Immunol; 1990 Jan; 144(2):691-8. PubMed ID: 2104902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A longitudinal study of the pharmacokinetics of cyclosporine A and in vitro lymphocyte responses in renal transplant patients.
    Tufveson G; Odlind B; Sjöberg O; Lindberg A; Gabrielsson J; Lindström B; Lithell H; Selinus I; Tötterman T; Wahlberg J
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):16-24. PubMed ID: 2947364
    [No Abstract]   [Full Text] [Related]  

  • 40. Studies on the biologic activities of Sandimmun metabolites in humans and in animal models: review and original experiments.
    Fahr A; Hiestand P; Ryffel B
    Transplant Proc; 1990 Jun; 22(3):1116-24. PubMed ID: 2140916
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.